共 50 条
- [41] Complement Inhibitor Eculizumab in Atypical Hemolytic Uremic Syndrome [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (08): : 1312 - 1316
- [42] Proteinuria and Exposure to Eculizumab in Atypical Hemolytic Uremic Syndrome [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (06): : 759 - 766
- [44] Critical appraisal of eculizumab for atypical hemolytic uremic syndrome [J]. JOURNAL OF BLOOD MEDICINE, 2016, 7 : 39 - 72
- [46] Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era [J]. AJP REPORTS, 2021, 11 (02): : E95 - E98
- [47] Success of eculizumab in the treatment of atypical hemolytic uremic syndrome [J]. Pediatric Nephrology, 2015, 30 : 783 - 789
- [49] ATYPICAL HEMOLYTIC UREMIC SYNDROME UNRESPONSIVE TO ECULIZUMAB THERAPY [J]. PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1648 - 1648
- [50] A Case of Atypical Hemolytic Uremic Syndrome Treated With Eculizumab [J]. PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1565 - 1565